Google exec at Mayo Clinic conference: AI, ML ‘is math, not magic’
Michael Howell, chief clinical officer of Google, discussed the ways AI and ML are serving healthcare, as well as some lessons he learned since he started working at Google.
Michael Howell, chief clinical officer of Google, discussed the ways AI and ML are serving healthcare, as well as some lessons he learned since he started working at Google.
The company said it had used its machine learning platform to generate multiple antibodies and peptides against the Covid-19 virus in less than 17 days and could potentially create hitherto "impossible" protein-based therapeutics.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The partnership includes a $30 million upfront payment from Bayer and potentially more than $100 million in milestones per program generated through the partnering of the German drugmaker's molecule library and Recursion's artificial intelligence-based drug discovery platform.
While the lead author of the study, at the Oak Ridge National Laboratory, cautioned that the researchers had not found a cure for the virus that causes COVID-19, they were able to identify 77 compounds after screening more than 8,000 in a matter of days.
The question of who owns the intellectual property to a drug born inside a computer came up in a panel discussion at a recent life sciences law symposium.
Notable CEO Matthew De Silva said the company has been able to successfully replicate its automated system, allowing for the export of the company's technology and growth of its commercial use cases.
A new partnership between Nvidia and the American College of Radiology will give a wider range of clinicians the ability to build, share and adapt their own AI models.
The in vivo molecule was discovered under a two-year-old partnership between the two companies to discovery drugs using artificial intelligence. It will be developed for COPD.
Topol's report posits a more individualized, patient-centered system driven by a population empowered by personal genomic and health information.
The problem, according to researchers, is not fitness trackers themselves, but privacy regulations woefully unprepared to deal with the new types of data being produced, collected and analyzed.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
A new report from the Duke University Margolis Center for Health seeks to shed light on the current state of AI technology in healthcare and how to effectively drive adoption of AI-based clinical support tools.
My educated guesses on where the payer market is headed in a rapidly changing healthcare landscape.
The company was founded last year and has developed technology that analyzes data from a combination of clinical and commercial devices to monitor and track the health status of patients at home.
A new software service from the company called Amazon Comprehend Medical uses machine learning and natural language processing to extract relevant medical information from doctors' notes, clinical trial reports and patient health records.
The company is hoping to boost the adoption of AI in medical imaging with new software development kits and deals with Ohio State University and the NIH.